Behind the Science

Can science change the future of hepatitis B?

Behind the Science

Show Notes

Experts Joyeta Das & Jessica Hicks discuss a disease that is so quiet and unassuming, it's often called 'the silent disease’ – Hepatitis B. Developed and funded by GSK.

Show note: In the third Behind the Science episode, Dr. Kat Arney speaks with Jessica Hicks, Senior Director of the World Hepatitis Alliance, and Joyeta Das, Senior Global Medical Director for hepatitis B at GSK, to take a closer look at a disease that affects hundreds of millions of people worldwide. Around 87 million people in China and an estimated 1.7 million people in the United States are living with chronic hepatitis B, yet awareness and understanding of the disease remain low. Here we explore Hepatitis B, unpacking the biology, the burden, and the challenges scientists face in tackling it. If you want to hear more episodes, make sure to subscribe to the podcast. For more on how today’s discoveries are shaping tomorrow’s health, you can visit Behind the Science at GSK.com

More from Behind the Science

Jul 21, 2026

Experts Kaivan Khavandi and Dave Singh discuss diseases that affect a fundamental aspect of life – breathing.

Jul 13, 2026

Kaivan Khavandi & Dave Singh discuss a disease that affects a fundamental aspect of life – breathing. Episode coming soon.

Jan 26, 2026

Experts David Payne and Alison Holmes explore one of today’s biggest health challenges - antimicrobial resistance. Developed and funded by GSK.

Jan 20, 2026

David Payne & Alison Holmes explore one of the biggest health challenges: antimicrobial resistance. Episode coming soon.

See all episodes →